Dr. Simon Bergman
Dr. Simon Bergman obtained his medical degree from McGill University in 2001 and pursued his postgraduate training in General Surgery. During this time, he obtained a M.Sc. focusing on surgical recovery and patient-centered outcomes. In 2008, he completed a fellowship in minimally invasive surgery at The Ohio State University, before returning to McGill University. Dr. Bergman has led a research program on the optimization of care in elderly patients and has published over 50 peer-reviewed articles and book chapters.
Dr. Bergman is currently an Associate Professor of Surgery at the Jewish General Hospital, where he specializes in minimally invasive (laparoscopic) surgery, with a practice focused on hernias and gallbladder disease, as well as spleen, adrenal, and stomach surgery. He is also an acute care surgeon, caring for patients presenting to the emergency room with acute biliary issues, appendicitis, and bowel obstruction.
Dr. Bergman is very active in surgical education. In addition to supervising students, residents, and fellows, he is the Director of Undergraduate Surgical Education at McGill University. In recognition of his contributions to surgical education, he recently received a Certificate of Merit from the Canadian Association of Medical Education. Finally, Dr. Bergman is currently serving his second term as Assistant Dean of Accreditation in Undergraduate Medical Education.
Dr. Jean-François Boileau
Dr. Boileau is an associate professor in the Departments of Surgery and Gerald Bronfman Oncology at McGill University. He is a surgical oncologist and director of the Breast Clinical Trials Group at the Montreal Jewish General Segal Cancer Centre and a founding member of the Quebec McPeak-Sirois Clinical Trials Consortium. He is an author on the breast neoadjuvant PALLET (Palbociclib), KRISTINE (Trastuzumab emtansine) and KEYNOTE-522 (Pembrolizumab) trials published in the Journal of Clinical Oncology, Lancet Oncology and in the New England Journal of Medicine.
As the Principle Investigator of the SN FNAC study (Journal of Clinical Oncology), he has contributed to establishing sentinel node biopsy as an acceptable option to re-stage the axilla of node positive breast cancer patients after neoadjuvant therapy.
Dr. Shannon Fraser
Dr. Shannon Fraser graduated from University of Toronto’s medical school, then completed residency in General Surgery, followed by a fellowship in Minimally Invasive surgery at McGill. She holds 2 master’s degrees, one in zoology and a second in experimental surgery (learning and simulation in MIS).
Dr. Fraser is an associate professor at McGill and has worked at the Jewish General Hospital since 2005, where she has been Division Chief for general surgery since 2009. Her clinical expertise lies in minimally invasive, hernia and acute care surgery, while her research interests include surgical education, surgical outcomes, and patient safety innovations, on which she has published several journal articles and book chapters.
She is passionate about doing the right thing, at the right time, for the right patient and as such, has been an institutional NSQIP champion, Chair of Pertinence of Practice, and most recently taken on the position of Medical Director for the CIUSSS West-Central Montreal C4 Command Centre. Dr. Fraser is also the current president for the Canadian Society of Physician Leaders.
Dr. Karyne Martel
Dr. Martel first obtained a bachelor degree in biomedical science from Université de Montréal before starting her medical training at the same institution. After graduating she pursued her specialization in General Surgery and later on completed a fellowship in General Surgical Oncology at McGill University. After practicing many years in the community, Dr. Martel was recruited as academic staff for her experience in breast oncology and acute care surgery.
Dr. Martel is currently an Associate Professor of Surgery and Oncology at the Jewish General Hospital where she specializes mainly in breast and melanoma surgery. Her main focus is breast oncoplastic surgery in the treatment of breast cancer. She has gained additional training from The School of Oncoplastic Surgery and the Brazilian Society of Mastologia and she is a member of the Oncoplastic Breast Consortium.
Dr. Jean-Sébastien Pelletier
Dr. Jean-Sébastien Pelletier is a Hepato-Pancreatico-Biliary (HPB) and general surgeon. His expertise lies in employing advanced minimally invasive techniques (including laparoscopic and robotic surgery) to treat complex HPB conditions, including liver, pancreas, and bile duct disorders. He also has an active acute care and elective General Surgery practice.
Dr. Pelletier’s academic interests include the use of minimally invasive surgery, virtual care for surgical patients as well as surgical education.
Dr. Pelletier also works at McGill as the Program Director for Surgical Foundations.
Dr. Ipshita Prakash
Accreditations
- Assistant Professor, Departments of Surgery and Oncology, McGill University
- Clinician Investigator, Lady Davis Institute for Medical Research
- Director, McGill Breast Outcomes Research Group
Post-Doctoral Training
- Breast Surgical Oncology Fellowship, Duke University, North Carolina
Education
- MD, McGill University Medical School, Montreal, Canada
- MSc Health Policy Planning & Financing, London School of Economics, London School of Hygiene & Tropical Medicine, London, United Kingdom
Research Focus
Ipshita Prakash MD, MSc, FRCSC is an assistant professor of surgery and oncology at McGill University and a breast surgical oncologist at the JGH Segal Cancer Centre in Montreal, Canada. Her research program focuses on health services research, specifically breast cancer related financial toxicity and access to specialized care.
With her research program, she hopes to examine breast cancer outcomes through an inter-disciplinary lens, decrease financial toxicity and improve access to breast cancer care, especially for underserved groups and mitigate disparities.
She directs the McGill Breast Outcomes Research Group and is a founding member of the McGill Global Oncology Program. She is also part of the World Health Organization’s Global Breast Cancer Initiative to reduce global breast cancer mortality.
Dr. Evan Wong
Dr. Evan Wong completed his Medical Degree and General Surgery residency at McGill University. During residency, he earned a Master’s of Public Health at the Johns Hopkins Bloomberg School of Public Health, where he specialized in Epidemiology & Biostatistics and access to trauma and surgical care in low-resource settings. He then pursued subspecialty training in Critical Care Medicine at McGill prior to returning to Johns Hopkins Hospital to complete a Trauma and Acute Care Surgery Fellowship.
Dr. Wong is cross appointed at the Jewish General Hospital and the McGill University Health Centre, as well as across the Departments of Surgery and Critical Care Medicine. He is certified by the Royal College of Surgeons of Canada in General Surgery and Critical Care Medicine and by the American Board of Surgery in General Surgery and Surgical Critical Care.
Dr. Wong is active in Undergraduate and Postgraduate Education. He has been appointed the lead for Trauma and General Surgery services in Nunavik and focuses on building patient-centered care pathways, quality improvement initiatives and healthcare professional education programs in conjunction with the local communities. His research interests focus on these goals, notably disparities in access to care, trauma systems and patient-centered outcomes.
Dr. Stephanie Wong
Stephanie Wong, MD MPH is an Assistant Professor of Surgery and Oncology at McGill Medical School and a breast surgical oncologist at the JGH Segal Cancer Centre in Montreal, Canada. She received her medical degree and completed general surgery residency at McGill University in 2018.
During her residency she completed an MPH at the Harvard School of Public Health, and in 2019, completed a breast surgical oncology fellowship at Dana-Farber/Brigham and Women’s Cancer Centre and Massachusetts General Hospital.
Her clinical and research interests focus on the surgical treatment of breast cancer patients and high-risk patient populations. She directs the High Risk Breast Clinic at the JGH Stroll Cancer Prevention Centre where she follows women with hereditary breast and ovarian cancer syndromes and those with a history of atypical breast biopsies.
In 2021 was a recipient of the FRQS Chercheurs Boursiers Cliniciens award for research on Optimizing Surgical Decision Making and Prevention Strategies for Women at Elevated Breast Cancer Risk.
Chana Notik
Chana Notik is the specialized nurse practitioner (SNP) in the Acute Care Surgery service. She earned her Bachelor's degree in Nursing from McGill University, and then pursued a Master's degree in Nurse Practitioner (NP) studies with a focus on Adult Care at the University of Toronto.
Chana has over a dozen years of nursing experience. Previously she worked as a nurse clinician in the Emergency Room, and then as an Oncology NP. She's also volunteered in various clinics in the rural areas of Guatemala, Nicaragua, and Uganda.
In addition to her inpatient practice, Chana is dedicated to research and quality improvement projects that aim to shorten hospital stays and reduce wait times. In particular, she has a special interest in breast cancer initiatives and enhanced accessibility and equality in healthcare.
Chana is also committed to educating the next generation of NPs. She is a guest lecturer at McGill University, and precepts NP students who come to JGH for their clinical rotations.